RU2526131C2 - Белки лизиса клеток vero, способ их получения и набор для определения белков клетки-хозяина для клеток vero, содержащий белки лизиса - Google Patents

Белки лизиса клеток vero, способ их получения и набор для определения белков клетки-хозяина для клеток vero, содержащий белки лизиса Download PDF

Info

Publication number
RU2526131C2
RU2526131C2 RU2010143974/15A RU2010143974A RU2526131C2 RU 2526131 C2 RU2526131 C2 RU 2526131C2 RU 2010143974/15 A RU2010143974/15 A RU 2010143974/15A RU 2010143974 A RU2010143974 A RU 2010143974A RU 2526131 C2 RU2526131 C2 RU 2526131C2
Authority
RU
Russia
Prior art keywords
proteins
vero
lysis
cells
antibodies
Prior art date
Application number
RU2010143974/15A
Other languages
English (en)
Russian (ru)
Other versions
RU2010143974A (ru
Inventor
Дзийинг КУИ
Юи ЛИУ
Вейксу ЛИУ
Джин ШИ
Сонгминг ШИ
Юе ЯО
Original Assignee
Шанхай Зерун Биотек Ко., Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CN2008100433197A external-priority patent/CN101570566B/zh
Priority claimed from CN2008100433182A external-priority patent/CN101571549B/zh
Application filed by Шанхай Зерун Биотек Ко., Лтд. filed Critical Шанхай Зерун Биотек Ко., Лтд.
Publication of RU2010143974A publication Critical patent/RU2010143974A/ru
Application granted granted Critical
Publication of RU2526131C2 publication Critical patent/RU2526131C2/ru

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
    • C12N2770/32451—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
RU2010143974/15A 2008-04-30 2008-08-07 Белки лизиса клеток vero, способ их получения и набор для определения белков клетки-хозяина для клеток vero, содержащий белки лизиса RU2526131C2 (ru)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CN2008100433197A CN101570566B (zh) 2008-04-30 2008-04-30 Vero细胞裂解蛋白、制备方法及其用途
CN2008100433182A CN101571549B (zh) 2008-04-30 2008-04-30 Vero细胞HCP检测试剂盒及其应用
CN200810043318.2 2008-04-30
CN200810043319.7 2008-04-30
PCT/CN2008/001434 WO2009132484A1 (fr) 2008-04-30 2008-08-07 Protéines lytiques de cellule vero, procédé de préparation de celles-ci et kit de détection pour vero hcp comprenant celles-ci

Publications (2)

Publication Number Publication Date
RU2010143974A RU2010143974A (ru) 2012-06-27
RU2526131C2 true RU2526131C2 (ru) 2014-08-20

Family

ID=41254761

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2010143974/15A RU2526131C2 (ru) 2008-04-30 2008-08-07 Белки лизиса клеток vero, способ их получения и набор для определения белков клетки-хозяина для клеток vero, содержащий белки лизиса

Country Status (4)

Country Link
KR (1) KR101632635B1 (fr)
BR (1) BRPI0822510B8 (fr)
RU (1) RU2526131C2 (fr)
WO (1) WO2009132484A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107228894B (zh) * 2017-01-24 2019-03-19 浙江海隆生物科技有限公司 一种油乳剂蛋白亚单位疫苗中蛋白含量和纯度的检测方法及其应用
CN117192107A (zh) * 2023-09-11 2023-12-08 福建基诺厚普生物科技有限公司 一种工艺特异性宿主细胞蛋白残留的检测方法及试剂盒

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2042360C1 (ru) * 1992-07-06 1995-08-27 Биотехнологическая компания "Биосервис" Набор для выявления хламидийной инфекции
WO2007117490A2 (fr) * 2006-04-05 2007-10-18 Abbott Biotechnology Ltd. Purification d'anticorps
WO2008006780A1 (fr) * 2006-07-11 2008-01-17 Bia Separations D.O.O. Procédé de purification de virus grippal

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1843507B (zh) * 2006-02-14 2010-04-21 中国医学科学院医学生物学研究所 一种人用腮腺炎病毒组份疫苗及其制备方法和应用

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2042360C1 (ru) * 1992-07-06 1995-08-27 Биотехнологическая компания "Биосервис" Набор для выявления хламидийной инфекции
WO2007117490A2 (fr) * 2006-04-05 2007-10-18 Abbott Biotechnology Ltd. Purification d'anticorps
WO2008006780A1 (fr) * 2006-07-11 2008-01-17 Bia Separations D.O.O. Procédé de purification de virus grippal

Also Published As

Publication number Publication date
BRPI0822510B8 (pt) 2021-05-25
RU2010143974A (ru) 2012-06-27
WO2009132484A1 (fr) 2009-11-05
BRPI0822510B1 (pt) 2020-12-01
KR101632635B1 (ko) 2016-06-22
KR20110009210A (ko) 2011-01-27
BRPI0822510A2 (pt) 2015-06-16

Similar Documents

Publication Publication Date Title
CN113009153B (zh) 一种基于磁微粒化学发光的新冠病毒中和抗体检测试剂盒及其应用
Grauballe et al. Optimized enzyme‐linked immunosorbent assay for detection of human and bovine rotavirus in stools: Comparison with electron‐microscopy, immunoelectro‐osmophoresis, and fluorescent antibody techniques
CN113009154B (zh) 一步法新型冠状病毒中和抗体磁性微球检测试剂盒及其应用
CN111929433B (zh) 一种非洲猪瘟病毒抗体elisa检测试剂盒及其制备方法
EP1991691B1 (fr) Détection des facteurs de pathogénicité de l'anthrax
CN112964884B (zh) 一种诊断标志物及其在covid-19诊断及冠状病毒既往感染检测中的应用
CN110642945B (zh) 一种通用型的口蹄疫病毒结构蛋白抗体及其阻断elisa检测试剂盒
Hornsleth et al. Detection of respiratory syncytial virus in nasopharyngeal secretions by ELISA: comparison with fluorescent antibody technique
CN113447659B (zh) 一种检测抗蛋白酶体亚基α1-IgG抗体的试剂盒
CN105675866A (zh) 用于检测o型fmdv抗体的固相阻断elisa试剂盒
CN110967480A (zh) 一种猪流行性腹泻病毒IgA抗体ELISA试剂盒的制备及应用
CN101672849A (zh) 鹿流行性出血病竞争酶联免疫吸附试验试剂盒及其制备方法和用途
CN111474346B (zh) 猪流行性腹泻病毒IgA和IgG抗体检测试剂盒及其制备方法和应用
US20230072761A1 (en) Immunoassay for Detecting Zika Virus Infection
RU2526131C2 (ru) Белки лизиса клеток vero, способ их получения и набор для определения белков клетки-хозяина для клеток vero, содержащий белки лизиса
US11067579B2 (en) Target marker GP73 for detecting steatohepatitis and detection application method
US20080206790A1 (en) Assay for determining the presence or amount of newly synthesized antibodies
CN109633163B (zh) 降钙素原/c反应蛋白二合一检测试剂盒
CN109799342A (zh) 一种o型口蹄疫病毒抗体竞争elisa检测试剂盒
CN102435732A (zh) 弓形虫IgM抗体免疫印迹试剂盒及其制备方法
CN111398594B (zh) 一种特异性检测黄热病毒ns1抗原的免疫诊断试剂盒
CN101571549B (zh) Vero细胞HCP检测试剂盒及其应用
CN112444626B (zh) 一种非洲猪瘟病毒抗体elisa检测试剂盒及其制备方法
EP3761029B1 (fr) Nouveau dosage pour le diagnostic d'infections par des nématodes
CN113248580B (zh) 一种诊断标志物及其在新型冠状病毒灭活疫苗保护效果评估中的应用

Legal Events

Date Code Title Description
PC41 Official registration of the transfer of exclusive right

Effective date: 20210830